Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
about
An Unusual Role for a Mobile Flavin in StaC-like Indolocarbazole Biosynthetic EnzymesA phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumorsCytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691Bioprospecting potential of halogenases from Arctic marine actinomycetes.Novel investigational therapies for treating biliary tract carcinoma.
P2860
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
@ast
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
@en
type
label
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
@ast
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
@en
prefLabel
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
@ast
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
@en
P2093
P2860
P1476
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
@en
P2093
Afshin Dowlati
Amitabh Chak
Charles L Hoppel
James Posey
Joanna Brell
Linda Rath
Ramesh K Ramanathan
Scot C Remick
Smitha Krishnamurthi
P2860
P2888
P356
10.1007/S00280-009-1005-X
P50
P577
2009-04-28T00:00:00Z
P6179
1012040491